Skip to content

Allphase Pharma Consulting, LLC

A Professional Service Provider for the Pharma Industry

Allphase Pharma Consulting, LLC
Menu

Primary menu

  • CONTACT
  • BLOGS
    • The Viewpoint
    • The News
    • Recent Literature
    • Did you know…?
    • QIDP Antibiotics
  • LEGAL
  • WELCOME

Secondary menu

  • The News
  • The Viewpoint
  • Did you know…?
  • Recent Literature
  • QIDP Antibiotics

Tag Archives: language issues

REGULATORY INTERACTIONS – 2 The “KATA” of Proper Behavior

Posted on August 5, 2025 by Harald — No Comments ↓

Language-related issues come up quite frequently.  Most interactions with regulators are held in English, but not all of them.  In China, it is Mandarin, and in Japan it is, well, Japanese.  In Europe, it is mostly English, but French and German occasionally creeps into the dialogue.  In China, even if Continue reading REGULATORY INTERACTIONS – 2 The “KATA” of Proper Behavior→

Share this:

  • Click to share on LinkedIn (Opens in new window) LinkedIn
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on X (Opens in new window) X
  • Click to print (Opens in new window) Print
  • Click to email a link to a friend (Opens in new window) Email
  • Click to share on WhatsApp (Opens in new window) WhatsApp

Like this:

Like Loading...
Posted in Did you know...?, The News, The Viewpoint | Tagged AFSSAPS, Allphase Pharma Consulting, CDE, cultural sensitivity, EMA, FDA, Harald Reinhart, Health Canada, Kata, language issues, NMPA, PMDA, regional regulatory differences, regulatory meeting preparation, situational awareness, SwissMedic, TGA, the proper way to behave | Leave a reply

Go back

Your message has been sent

Rating(required)
Warning

Footer Menu

Footer menu

  • CONTACT
  • BLOGS
  • LEGAL
  • WELCOME
  • Email
Copyright © 2026 Allphase Pharma Consulting, LLC. All Rights Reserved.
Theme: Catch Box by Catch Themes
Scroll Up
%d